About one in 20,000 infants is born with what's called a congenital giant nevus—a huge, pigmented mole that may cover much of the face and body. Due to the mole's appearance and its risk of later developing into skin cancer, ...
May 12, 2022
0
95
Multiple sclerosis (MS) patients treated with Rituximab have better responses to the COVID-19 vaccine if they have higher B cell counts. This is the finding of a study from Uppsala University published in the journal JAMA ...
May 12, 2022
0
65
Researchers from the University of Adelaide and the Radboud University Medical Centre in the Netherlands have repurposed an arthritis drug to restrict the use of antibiotics in the treatment of side effects caused by blood ...
May 12, 2022
0
18
Evidence continues to gather that "long COVID," that is, continued negative health impacts months after apparent recovery from severe COVID-19, is an important risk for some patients. For example, researchers from the University ...
May 12, 2022
0
128
Less than half of Americans who received treatment for opioid use disorder over a five-year period were offered a potentially lifesaving medication, researchers at Washington University School of Medicine in St. Louis and ...
May 10, 2022
0
45
When a non-metastatic brain tumor—a meningioma—recurs after surgery and radiation treatment, a patient is out of options. No drugs are approved for these aggressive tumors, which occur in up to 20% of cases and can lead ...
May 9, 2022
0
615
Next-generation drugs against the sometimes fatal disease amebiasis could result from a RIKEN researcher's new strategy targeting a source of iron that an infectious protozoan parasite needs to proliferate.
May 9, 2022
0
77
The virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism.
May 4, 2022
0
107
Weill Cornell Medicine researchers have identified a protein in Mycobacterium tuberculosis (Mtb) that contributes to drug tolerance, a phenomenon that allows bacteria to survive treatment with drugs that would normally kill ...
May 4, 2022
1
43
Based on the findings of a new study led by the Translational Genomics Research Institute (TGen), part of City of Hope, a coast-to-coast clinical trial is planned that, if successful, could lead to FDA approval of the first ...
May 3, 2022
0
70
